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Abstract
The Vpx protein of human immunodeficiency virus type 2 (HIV-2) is a viral accessory protein related to, but distinct from, the
Vpr protein of HIV-1. Vpx is packaged into virions and, as a component of the viral preintegration complex (PIC), Vpx is required
for efficient virus replication in nondividing cells. Therefore, the localization of Vpx in cells is dynamic and dependent upon discrete domains of the protein. Expressed in the absence of other viral proteins, Vpx localizes to the nucleus of cells. However, if expressed with the Gag protein of HIV-2, Vpx localizes to the plasma membrane of cells. To further understand the regulation of
Vpx localization, we fused regions of Vpx to β-galactosidase to identify regions of the protein sufficient to mediate nuclear localization. The minimal transferable region of Vpx that conferred nuclear localization in these assays was aa 65 to 72. Alanine substitution of K68 and R70 in a GFP-Vpx construct abolished nuclear localization, suggesting that the basic residues in this region are
important for nuclear import. Analysis of the membrane transport of several GFP-Vpx alanine mutants demonstrated that while
separable, the domains of Vpx required for nuclear localization are not distinct from the domains required for membrane transport. The results of heterokaryon shuttling assays indicated that Vpx is not a shuttling protein; however, HIV-2 Vpr did shuttle
similar to HIV-1 Vpr.

of the PIC, it remains unclear as to the exact contribution
each protein plays. In addition, the central DNA flap has
also been shown to be an important signal for nuclear entry of the PIC (Zennou et al. 2000).
There is significant sequence homology among the
Vpr and Vpx proteins (Tristem et al. 1990 and Tristem et
al. 1998). Both are of similar size (14–17 kDa), are packaged in virions, and possess similar functions (Fletcher et
al. 1996). The Vpr protein of HIV-1 has been extensively
studied and demonstrated to possess at least two discrete
functions. Early in virus replication, Vpr mediates infection of nondividing cells by directing nuclear import of
viral PICs (Popov et al. 1998). Vpr contains two discrete
NLSs that directly target to the nuclear pore complex
(NPC) and facilitate entry into the nucleus (Jenkins et al.
1998). It has also been proposed that Vpr-induced herniation of the nuclear envelope structure may facilitate PIC
import (De Noronha et al. 2001). Vpr has also been demonstrated to cause G2 cell-cycle arrest of proliferating cells
(Goh et al. 1994). This effect may contribute to increased

Introduction
Productive infection of nondividing cells by the human
and simian immunodeficiency viruses (HIV and SIV, respectively) requires active nuclear transport of the viral
DNA across the host cell nuclear membrane prior to viral dsDNA integration into the host genome. This task is
accomplished through the viral preintegration complex
(PIC), a nucleoprotein complex composed of cellular and
viral components (reviewed in Fouchier and Malim 1999).
The viral components include the dsDNA, reverse transcriptase, matrix, nucleocapsid, integrase, and Vpr (HIV1) or Vpx (HIV-2/SIV) proteins (Bukrinsky et al. 1993b,
Farnet and Haseltine 1991, Hansen and Bushman 1997,
Heinzinger et al. 1994, and Miller et al. 1997). The matrix,
integrase, Vpr, and Vpx proteins have each been identified as having karyophilic properties (Bukrinsky et al.
1993a, Gallay et al. 1997, Heinzinger et al. 1994, and Pancio et al. 2000). Although each of these proteins has been
demonstrated to be a crucial regulator of nuclear import


 

virus production since viral transcription is most active
during this phase of the cell cycle (Goh et al. 1994). Interestingly, two nonarresting mutants of Vpr failed to alter
nuclear membrane morphology, suggesting that nuclear
membrane disruption may contribute to G2 cell-cycle arrest (De Noronha et al. 2001). HIV-1 Vpr has also been
demonstrated to be a shuttling protein capable of nuclear
import and export (Sherman et al. 2001). While the role of
shuttling on Vpr function has not been elucidated, it has
been shown to be dispensible for packaging of Vpr into
virions (Jenkins et al. 2001). Mutation of the nuclear export signal of Vpr abolished Vpr-mediated nuclear membrane herniation (De Noronha et al. 2001). Together, these
results suggest that Vpr shuttling may be important for
Vpr-mediated cell-cycle arrest.
Unlike HIV-1, HIV-2 contains both the vpr and the vpx
genes, each with discrete functions (Fletcher et al. 1996).
HIV-2 Vpr has been demonstrated to arrest cells in G2,
but plays no role in nuclear import of the PIC (Fletcher
et al. 1996). Vpx is a 17-kDa, 112 amino acid (aa) protein
that is packaged into virions but is not crucial for virion
morphology. HIV-2 Vpx is necessary for efficient replication in nondividing cells (Pancio et al. 2000). As a component of the HIV-2 PIC, Vpx, similar to HIV-1 Vpr, has
been shown to be necessary and sufficient for nuclear
translocation of the PIC, but plays no role in integration
(Hansen and Bushman 1997). As such, Vpx plays an important role in the early steps of virus replication. Indeed,
SIVsm Vpx has been demonstrated to be required for virus dissemination and pathogenesis in vivo (Hirsch et al.
1998). This may be due to the nuclear import role of Vpx
in allowing infection of quiescent cells. The cellular localization of Vpx is dynamic and dependent upon discrete
domains within the protein. Expressed in the absence of
other HIV-2 components, Vpx exhibits a predominantly
nuclear localization, with limited perinuclear localization
(Mahalingam et al. 2001 and Pancio et al. 2000). However,
expressed in the presence of HIV-2 Gag, Vpx is observed
to localize to the plasma membrane (Pancio et al. 2000).
The interaction of Vpx and Gag facilitates the packaging
of Vpx during virus assembly. Plasma membrane localization and packaging of Vpx are mediated through the
interaction of aa 81–86 of Vpx with aa 15–40 of the HIV-2
p6 protein (Jin et al. 2001 and Selig et al. 1999).
Previous work suggested that the C-terminus of Vpx
contained an NLS (Pancio et al. 2000). These studies demonstrated that deletion of the 11 C-terminal aa of Vpx
abolished nuclear localization of a GFP-Vpx fusion, resulted in decreased nuclear import of viral PICs, and decreased virus replication in macrophage cultures. These
studies were confirmed in another article (Mahalingam et
al. 2001). Using GFP fusion proteins, this study also identified an NLS in a broad region of Vpx (aa 60–85) (Mahalingam et al. 2001). Several mutations in this region, including both charged (H82) and hydrophobic residues
(L74 and L75), abolished nuclear localization. Other Cterminal mutations were also found to be deleterious to
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Vpx nuclear localization, further suggesting the C-terminus of Vpx (aa 60–112) is required for full nuclear targeting capability. Here we report that aa 65 to 72 is the
minimal transferable region of Vpx that contains nuclear localization properties. Furthermore mutation of basic residues in this region disrupted nuclear localization
of a GFP–Vpx fusion, but was not deleterious to membrane transport in the presence of Gag- Pol. These results
demonstrate that the nuclear localization and membrane
transport of Vpx are separable. However, other mutations
C-terminal to this region in Vpx disrupted both nuclear
localization and membrane transport, indicating that the
requirements for both functions are not discrete. Defining
the mechanism of Vpx nuclear import may lead to the development of therapeutic interventions at early stages of
virus replication.
Results
Construction and expression of lacZ–vpx fusions
Published reports conflict as to the exact size limit (40–60
kDa) of proteins capable of passive diffusion between the
nucleus and cytoplasm of cells. Therefore, to identify the
domain(s) of Vpx that facilitates nuclear localization, we
constructed a series of lacZ–vpx fusions. The use of β-galactosidase (β-gal) as a fusion partner for the Vpx fragments
resulted in proteins greater than 100 kDa in size, which

Figure 1. Amino acid sequence of HIV-2 ROD Vpx and expression of β-gal–Vpx fusion proteins. (A) Amino acid sequence of
HIV-2 ROD Vpx. (B) Western blot of lysates from 293T cells
transiently transfected with indicated lacZ–vpx fusions (numbers indicate aa of Vpx present in fusion). Fusion proteins
were detected using a monoclonal anti-β-gal antibody followed by an alkaline phosphatase conjugated anti-mouse secondary antibody. Antibody binding was detected using Western blue (Promega) colorimetric substrate.
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Figure 2. Subcellular localization of β-gal–Vpx fusion proteins. β-gal–Vpx fusion proteins were detected in transiently
transfected HeLa cells by indirect immunofluorescence as described under Materials and methods. The regions of Vpx
contained in each fusion are given. Nuclei were visualized by staining with DAPI and are shown in panels to the right
of the immunofluorescence images.
would require active transport to move into and out of
the nucleus. Full-length and smaller regions of vpx (Figure 1A) were inserted at the 3′ end of the lacZ gene in a
eukaryotic expression vector pCR3.1 (Invitrogen). The
nuclear localization signal (NLS) of the large T antigen of
SV40 was used as a positive control. Expression of these
β-gal–Vpx fusion proteins was detected by Western blot
of transiently transfected 293T cells using an anti-β-gal
monoclonal antibody (Promega) (Figure 1B). All proteins
were of the predicted size.
Amino acids 61 to 75 of Vpx facilitate nuclear localization of
heterologous proteins
The localization of the β-gal fusions was first assessed
by immunofluorescence microscopy of transiently transfected HeLa cells using an anti-β-gal antibody (Promega),
followed by a FITC-conjugated secondary antibody (Figure 2). β-Gal alone localized exclusively to the cytoplasm
of cells and, as expected, the lacZ-NLS positive control
was observed exclusively in the nuclei of transfected cells.
The fusion containing full-length Vpx was also observed
to have a predominantly nuclear phenotype. Analysis of
the β-gal fusion containing partial fragments of Vpx (βgal:61–112, β-gal:61–79) indicated that amino acids 61–79
conferred a predominantly nuclear phenotype similar to
full-length Vpx. However, fusion proteins lacking this re-

gion (e.g., β-gal:1–60, β-gal:86–112) demonstrated diffuse
cellular staining or only cytoplasmic localization. These
findings are consistent with a previous report by Mahalingam et al.. demonstrating that aa 60–85 contained a
transferable NLS (Mahalingam et al. 2001). Further dissection of this region with overlapping Vpx regions (aa 61–
72, 65–75, 69–79) demonstrated that both aa 61–72 and aa
65–75 conferred a predominantly nuclear phenotype, suggesting that the overlapping region (residues 65–72) contained an NLS.
To confirm the immunofluorescence data, cells transiently transfected with the lacZ–vpx expression plasmids
were fractionated and β-gal assays were performed to determine the level of activity in the nuclear and cytoplasmic compartments. Separation of the cytoplasmic and nuclear extracts was confirmed by the lack of detection of
the cytoplasmic protein lactate dehydrogenase (LDH) in
the nuclear fraction (data not shown). The β-gal results
were expressed as a ratio of the nuclear to cytoplasmic
(N/C) activity. Therefore, a ratio > 1.0 would indicate a
predominantly nuclear protein. Indeed, the N/C ratio of
the β-gal-NLS positive control was >7.0. The N/C ratio
for β-gal alone was ~1.0 (Figure 3), which is defined as cytoplasmic in this assay. Indeed, those fusion proteins observed to be cytoplasmic by immunofluorescence all exhibited a N/C ratio of 0.84–1.43. In contrast, all fusion
proteins that contained Vpx amino acid residues 65–72 ex-
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hibited a N/C ratio > 2.0, confirming the results observed
with the immunofluorescence. However, the ratios of the
fusions that contained smaller fragments of Vpx were reduced in comparison to the full-length β-gal–Vpx fusion,
suggesting other regions of Vpx may enhance nuclear localization or retention.
Alanine scanning mutagenesis of Vpx nuclear localization
Amino acids 65 to 72 are highly conserved among HIV2 and SIV strains. This region contains several tyrosine
residues and two basic residues (K68 and R70). To further
analyze the nuclear targeting potential of this region, we
constructed several pEGFP-Vpx clones with alanine substitutions in this region and assessed their cellular localization in transient transfection assays (Figure 4). Alanine
substitution of the two serines at positions 63 and 65 did
not impair nuclear targeting of the fusion protein. However, alanine substitution of the two basic residues alone
(A68,70) or together with the tyrosine residues (A66,68–
71) abolished nuclear targeting of the fusion proteins, indicating that these two residues are critical for nuclear
targeting of the fusion protein. These results further suggest that aa 65–72 of Vpx is an NLS. We had previously
constructed several alanine-scanning mutants of Vpx in
the context of a molecular clone (Jin et al. 2001). Two of
these mutants (A74–80 and A80–86) were cloned into the
GFP fusion vector and their localization was assessed by
fluorescence microscopy. Both mutants produced interesting phenotypes. The mutant with alanine substitutions
of aa 74 to 80 (A74–80) displayed a predominantly cytoplasmic phenotype compared to wild-type GFP-Vpx, suggesting this region is also important for nuclear localization of Vpx. Another mutant, with alanine substitutions
of aa 80–86 (A80–86), while able to enter the nucleus of
cells, appeared to accumulate on the nuclear membrane,
suggesting a partial defect in nuclear translocation. These
data are consistent with previous work from our laboratory and others that identified numerous mutations C-terminal to aa 65–72 that disrupted nuclear targeting of Vpx
(Mahalingam et al. 2001 and Pancio et al. 2000).
Membrane transport and subsequent packaging of Vpx
into virions require an interaction with the p6 region of
Gag. To assess the membrane transport capability of each
alanine scanning mutant, we cotransfected each GFP-Vpx
mutant plasmid with a HIV-2 Gag-Pol plasmid (pTMGP2) expressed by the T7-vaccinia expression system. As
previously described (Pancio et al. 2000), GFP-Vpx was
observed at the membrane of cells when coexpressed with
Gag-Pol ( Figure 5, arrows). Alanine substitution of aa
74–80 and 80–86 had been previously shown to be deleterious to Vpx packaging (Jin et al. 2001) and, as expected,
both mutants failed to demonstrate membrane targeting
when expressed with Gag-Pol ( Figure 5). The three other
alanine mutants (A63,65; A66,68–71; A68,70) exhibited
membrane localization similar to wild-type GFP-Vpx, indicating that alanine substitution in this region was not
deleterious to targeting of Vpx to the membrane. Further-
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more, these results demonstrate that nuclear localization
and membrane targeting are separable, but not discrete
since A74–80 is deficient for both nuclear targeting and
membrane transport.
HIV-2 ROD Vpx is not a shuttling protein
Recent studies have identified HIV-1 Vpr as a shuttling
protein (Sherman et al. 2001). While the role of nuclear export of Vpr has not been elucidated, it has been demonstrated that shuttling is not required for packaging of Vpr,
but may be important for Vpr-mediated cell-cycle arrest
(Jenkins et al. 2001). Given the homology between Vpr and
Vpx, we therefore examined whether Vpx was a shuttling
protein. To determine whether Vpx shuttled, we used a
heterokaryon shuttling assay developed by (Jenkins et al.
2001). In this assay, HeLa cells transiently transfected with
GFP fusion proteins were plated onto mouse L cells and
treated with polyethylene glycol (PEG) to initiate cell fusion. Cells were washed and incubated for an additional
3 h in the presence of cycloheximide. Cells were fixed and
permeabilized, and nuclei were stained with DAPI. DAPI
staining of L cells results in nuclei with bright, punctate,
foci that are easily distinguishable from the HeLa cell nuclei ( Figure 6, right panel, denoted with arrows). Shuttling can be observed under a fluorescence microscope by
the movement of the GFP fusion protein to the L cell nuclei. For our studies, a GFP–HIV-1 Vpr fusion protein was

Figure 3. β-gal–Vpx fusions containing Vpx aa 65 to 72 localize
primarily to the nucleus of transfected cells. 293T cells transiently transfected with the indicated expression vectors were
fractionated and the β-gal activity was determined for the cytoplasmic and nuclear fractions. Separation of the cytoplasmic
and nuclear fractions was monitored by detection of the cytoplasmic LDH protein in the nuclear fraction using a commercially available kit (Sigma). Results are expressed as the ratio of
nuclear to cytoplasmic (N/C) activity of the β-gal–Vpx fusion
proteins. Error bars denote the standard error of the mean.
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Figure 4. Alanine substitution of critical residues abolishes GFP–Vpx nuclear localization. Epifluorescence images of HeLa cells
transiently transfected with GFP–Vpx fusion proteins containing the indicated alanine substitutions. After fixation, cells were permeabilized and nuclei were stained with DAPI (right panels).

used as a positive control, which was observed in the L
cell nuclei (Figure 6). GFP-HIV-2 Vpx, however, did not
move into the L cell nuclei when tested, indicating that
shuttling did not occur. Transient transfection of GFPHIV-2 Vpx into L cells alone produced a nuclear phenotype, confirming that the absence of GFP-HIV-2 Vpx in
the L cell nuclei in the fusion assays was due to an absence of nuclear export from the HeLa cell nuclei and not
a failure of nuclear import into L cells (data not shown).
We also assessed whether a GFP–HIV-2 Vpr fusion protein could shuttle ( Figure 6). Similar to HIV-1 Vpr, the
GFP–HIV-2 Vpr protein was able to translocate from the
HeLa nuclei to the L cell nuclei. The lack of shuttling of
Vpx is consistent with the hypothesis that the shuttling of

HIV-1 and HIV-2 Vpr is not required for virion incorporation or PIC import, but rather may be important for another function of Vpr, such as cell-cycle arrest.
Discussion
Nuclear localization of HIV-2 Vpx is necessary for the
import of the viral preintegration complex into the nucleus of nondividing cells (Fletcher et al. 1996 and Pancio et al. 2000). Studies by Mahalingham et al.. had identified an NLS within aa 60–85 of Vpx and demonstrated
that several residues within this region were critical for
Vpx nuclear localization and virus replication in nondi-
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viding cells (Mahalingam et al. 2001). The current studies
have extended this work and identified a minimal transferable nuclear localization signal of HIV-2 Vpx to aa 65–
72 (…SYTKYRYL…). This stretch of amino acids is highly
conserved among HIV-2/SIV strains, further suggestive
of the importance of this region. Classical NLSs are commonly either monopartite or bipartite. Monopartite NLSs
are characterized by a single stretch of three or more basic residues, whereas bipartite NLSs are composed of two
stretches of basic residues separated by approximately
10 amino acids. The Vpx NLS has two basic residues (K68
and R70) and several tyrosines, but lacks a run of basic
residues homologous to the classical monopartite NLS.
Similarly, analysis of the surrounding amino acids failed
to identify a motif consistent with a bipartite NLS. However, alanine substitution of K68 and R70 abolished nuclear
localization of GFP-Vpx, demonstrating that the basic residues are critical components of the Vpx NLS. Therefore,
given the absence of either a classical monopartite or bipartite NLS, it is likely that Vpx may require novel protein–protein interactions to move across the nuclear pore.
Although previous studies (Mahalingam et al. 2001
and Pancio et al. 2000) have demonstrated that mutations
C-terminal to the NLS are deleterious to Vpx nuclear localization, we were able to map an NLS to a 10-aa region.
However, the functional β-gal fractionation data would
suggest that only full-length Vpx maintains complete nuclear import capability. There are several possibilities to
explain this discrepancy. The most obvious explanation
is that the mutations/deletions that have been previously
reported may alter Vpx structure such that the NLS is
compromised and no longer completely functional. A second possibility is that the C-terminal mutations disrupt
another function of Vpx required for full nuclear import
capability. Further studies would be needed to characterize the C-terminus of Vpx and identify any novel functional domains that affect the nuclear transport of Vpx. A
third theory to explain this discrepancy could be the presence of a second NLS, such as demonstrated for HIV-1
Vpr (Jenkins et al. 1998). However, we feel that the broad
panel of β-gal–Vpx fusions we tested would have likely
identified a second NLS, if present. Finally, it could also
be possible that β-gal may have compensated for a domain in Vpx to facilitate nuclear import. β-Gal may have
provided a domain in trans to enhance a weak NLS in the
smaller fusion proteins. Alternatively, since β-gal exists as
a tetramer in vivo, the protein could have enhanced nuclear targeting of the smaller fusions by multiplying the
effect of a single, weak NLS. Therefore, a tetramer of fusion proteins containing four weak NLSs would appear to
Figure 5. Membrane targeting of GFP–Vpx alanine mutants.
U87 cells were infected/transfected as described under Materials and methods with the indicated GFP–Vpx expression
plasmids with or without the GagPol expression plasmid
pTM-GP2. Sixteen hours later cells were fixed and mounted,
and images were obtained. Membrane localization is denoted
by arrows.
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Figure 6. HIV-2 Vpx does not shuttle. HeLa cells were transiently transfected with the indicated GFP fusion plasmids 18 h prior to
being plated onto L cells. After allowing the HeLa cells to settle, the cells were fused with PEG, washed, and incubated an additional 3 h in the presence of cycloheximide. Cells were fixed, permeabilized, and stained with DAPI (right panels). L cells stained
with DAPI (denoted with arrows) exhibit a bright, punctate staining in comparison to HeLa cells. Shuttling is demonstrated by
the movement of the GFP fusion protein into the L cell nuclei.

have stronger karyophilic properties. Nevertheless, while
a larger domain of Vpx may be necessary for full function, our results demonstrate that aa 65–72 are residues
critical for the karyophilic properties of HIV-2 Vpx.
In the presence of Gag, Vpx is trafficked to the plasma
membrane via an interaction with p6 (Selig et al. 1999).
Previous work demonstrated that mutation of aa 74–86 of
Vpx reduced Vpx incorporation into virus-like particles
and aa 80–86 were important for Vpx–Gag interactions (Jin
et al. 2001). Consistent with these findings, alanine substitution of aa 74–80 or 80–86 abolished membrane transport
of GFP-Vpx fusions. The alanine substitution of K68 and
R70 abolished nuclear localization of GFP- Vpx, but had
no effect on Vpx membrane transport, demonstrating that
the nuclear localization and membrane transport func-

tions are separable within Vpx. Alanine substitution of aa
74–80, however, was deleterious to both nuclear localization and membrane transport, indicating that these functional domains are not discrete. These findings support a
model of Vpx transport whereby the interaction of Vpx
with the p6 region of Gag suppresses the NLS of Vpx to
target Vpx to the plasma membrane of cells for incorporation into virions.
The functions of HIV-1 Vpr are shared between HIV2 Vpr and Vpx. Both proteins are packaged into virions and associate with the reverse transcription complex
early after infection of cells (Fletcher et al. 1996); however,
only Vpx is thought to play a role in PIC nuclear import
(Fletcher et al. 1996). Recently, HIV-1 Vpr was identified
as a shuttling protein (Sherman et al. 2001). Although the
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functional significance of HIV-1 Vpr shuttling is not clear,
it has been demonstrated that HIV-1 Vpr shuttling is not
necessary for packaging into virions (Jenkins et al. 2001).
Our studies indicated that HIV-2 Vpr, but not Vpx, is a
shuttling protein. The inability of HIV-2 Vpx to shuttle is
consistent with the idea that shuttling is not necessary for
the packaging of Vpr/Vpx proteins (Jenkins et al. 2001).
Furthermore, the inability of Vpx to shuttle suggests that
shuttling plays no role in the nuclear import of the HIV2 PIC. Rather, since HIV-2 Vpr shuttles, it would seem
likely that shuttling is important for Vpr-mediated G2
cell-cycle arrest or another undefined function.
We have identified a minimal NLS of HIV-2 Vpx; however, questions still remain to define the exact role of Vpx
in PIC nuclear import. The lack of a “classical” NLS suggests that Vpx may use a novel pathway to access the nuclei of cells. Future studies to identify cellular proteins
that interact with Vpx will further define the pathway
through which Vpx accesses the nucleus and the role the
Vpx protein plays as a component of the HIV-2 PIC. Delineation of the role the Vpx/Vpr proteins play in the nuclear import of the PIC may lead to the development of
novel therapeutic interventions of HIV infection.
Materials and methods
Plasmid construction
Plasmids pTM-GP2 and pEGFPVpx have been previously described (Horton et al. 1994 and Pancio et al. 2000).
To construct lacZ fusions, the lacZ ORF was PCR amplified from pCH110 (Amersham Biosciences, Piscataway, NJ) using Redi-Taq as described by the manufacturer (Sigma-Aldrich, St. Louis, MO). Primer sequences
are available upon request. The 3′ primer in the reaction
contained an artificial XhoI restriction site inserted immediately 5′ of the stop codon. The PCR product was TA
cloned into pcDNA3.1/V5-His-TOPO as described by the
manufacturer (Invitrogen, Carlsbad, CA). Positive clones
(pclacZ(XhoI)) were identified by restriction mapping
and sequencing the 5′ and 3′ insert junctions. All vpx inserts for fusion vectors were cloned into the XhoI site of
the plasmid. For full-length and larger segments of vpx,
regions were PCR amplified with HIV-2 ROD-specific
PCR primers containing XhoI sites on both 5′ and 3′ primers, with premature stop codons in the 3′ primers of truncated fragments. For regions of 12 aa or less, overlapping
primers were synthesized (IDT Technologies, Iowa City,
IA), annealed, phosphorylated, and ligated into digested
pclacZ(XhoI). All clones were confirmed by sequence
analysis. Alanine substitutions were inserted into pEGFPVpx by Excite Mutagenesis (Stratagene, La Jolla, CA) as
described by the manufacturer using primers with sitespecific substitutions. Alanine substitutions were confirmed by sequence analysis.
Fractionation assays
293T cells were maintained in Dulbecco’s modified Eagle’s
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medium supplemented with 10% fetal calf serum and penicillin/streptomycin. Cells were transfected using TransITLT1 reagent with 2–4 μg of indicated lacZ-fusion plasmids
as described by the manufacturer (PanVera, Madison, WI).
Forty-eight hours posttransfection, cells were harvested by
treatment with PBS + 5 mM EDTA and transferred to 1.5
mL microcentrifuge tubes. Nuclear and cytoplasmic fractions were obtained using a commercially available kit
(Pierce Chemical Co., Rockford, IL). Separation of the fractions was confirmed by lack of detectable LDH enzyme
in the nuclear fractions using a commercially available kit
(Sigma-Aldrich). Protein concentrations of each fraction
were determined using a commercially available kit (Pierce
Chemical Co.). The enzymatic activity of the β-gal fusion
was determined using a colorimetric microtiter plate assay.
Results are presented as a ratio of the nuclear to cytoplasmic β-gal activity. The results for each fusion represent at
least three independent experiments, with three separate
transfections per experiment.
Immunofluorescence analysis
HeLa cells (5 × 105) seeded onto glass coverslips were
transfected with 2 μg of lacZ fusion expression plasmids
as described above and incubated overnight. Cells were
washed, fixed with 4% paraformaldehyde in PBS, washed
again, and then permeabilized with 0.2% Triton X-100 in
PBS for 5 min. β-Gal was detected using a monoclonal antibody (Promega), followed by a FITC-conjugated antimouse IgG secondary antibody (Sigma). After the antibody incubations, the cells were incubated for 5 min with
2 μg/mL DAPI to allow for visualization of nuclei. Cells
were visualized and images obtained using a fluorescence
microscope equipped with an Optronics Magnafire imaging system (Optronics, Goleta, CA). Multiple images were
obtained from at least two independent transfections and
images presented in figures are representative of the dominant phenotype observed.
GFP-Vpx mutant localization and membrane transport assays
U87 cells maintained in DMEM supplemented with 15%
FBS and penicillin/streptomycin were plated onto glass
coverslips in six-well plates. For localization assays, HeLa
cells were transfected with 2 μg of indicated expression
plasmid as described above. For membrane transport assays, U87 cells were infected with VPT7-3 vaccinia virus
for 1 h in OptiMEM (Invitrogen) and then transfected in
normal media with 2 μg of indicated GFP-Vpx mutant
or 1 μg GFP-Vpx mutant, and 1 μg pTM-GP2. U87 cells
were grown overnight, fixed with 4% paraformaldehyde
in PBS, washed 3× in PBS + 1% FBS, and mounted onto
slides. For localization studies, HeLa cells were permeabilized with 0.2% Triton X-100 for 5 min after fixation and
washed, and nuclei were stained with 2 μg/mL DAPI and
washed again prior to mounting. Slides were visualized
and multiple images obtained as described above. Images
presented in figures are representative of the dominant
phenotype for each mutant.

identification of the nuclear localization signal of

Heterokaryon shuttling assays
HeLa and L cells were maintained as described above.
HeLa cells (5 × 105) were seeded into one well of a sixwell plate and the next day were transfected with 2 μg of
GFP-fusion plasmid. That same day, L cells were seeded
onto coverslips in six-well plates at a density of 5 × 105
cells/well. The next day, the HeLa cells were trypsinized and plated onto the L cells. After allowing the HeLa
cells to settle (3–5 h), the coverslips were removed and inverted onto 50% w/v PEG (Sigma-Aldrich) for 2 min to
initiate cell–cell fusion. The cells were then washed with
PBS and incubated for an additional 2 h in media containing 50 μg/mL cycloheximide. Cells were fixed, permeabilized, stained with DAPI, and mounted, and images were
obtained as described above.
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